Clinical Trial Update: Topotecan in Treating Patients With Myelodysplastic Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating topotecan in patients with myelodysplastic syndromes has completed. The study also included patients with leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Topotecan (topotecan)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 2 | Status: COMPLETED